American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Rosenberg
    Rosenberg
  3. Drilon
    Drilon
  4. Berger
    Berger
  5. Robson
    Robson
  6. Solit
    Solit
  7. Bajorin
    Bajorin
  8. Scher
    Scher
  9. O'Reilly
    O'Reilly
  10. Riely
    Riely

Groups

  1. Department of Medicine (459)
  2. Solid Tumor Oncology Division (401)
  3. Genitourinary Oncology Service (130)
  4. Survivorship Research (112)
  5. Population Sciences Research Program (101)
  6. Gastrointestinal Oncology Service (98)
  7. Epidemiology and Biostatistics (97)
  8. Hematologic Malignancies, Division of (96)
  9. GSK Faculty (84)
  10. Surgery (76)
Search Within
  1. "2018"
Formats
  1. Meeting Abstract (475)
  2. Journal Article (129)
Groups
  1. Department of Medicine (459)
  2. Solid Tumor Oncology Division (401)
  3. Genitourinary Oncology Service (130)
  4. Survivorship Research (112)
  5. Population Sciences Research Program (101)
  6. Gastrointestinal Oncology Service (98)

More Groups

People
  1. Robert Motzer (27)
  2. Matthew Hellmann (23)
  3. Michael Berger (23)
  4. Jonathan Rosenberg (22)
  5. Alexander Drilon (21)
  6. David Solit (19)

More People

Years
  1. 2018 (604)
Publications
  1. Journal of Clinical Oncology (562)
  2. JCO Precision Oncology (13)
  3. Journal of Oncology Practice (13)
  4. American Society of Clinical Oncology Educational Book (12)
  5. JCO Clinical Cancer Informatics (4)

Results (604)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of exercise on psychological burden in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Tonorezos, E. S.; Ford, J.; Wang, L.; Ness, K. K.; Yasui, Y.; Leisenring, W. M.; Sklar, C. A.; Robison, L. L.; Oeffinger, K. C.; Nathan, P. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for patients (pts) with locally advanced or metastatic breast cancer (BC): A meta-analysis
    Meeting Abstract

    Tio, M.; Patil, S.; Traina, T. A.; Robson, M. E.; Khasraw, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Updated efficacy, safety, & PD-L1 status of patients with HR+, HER2-metastatic breast cancer administered abemaciclib plus pembrolizumab
    Meeting Abstract

    Tolaney, S. M.; Kabos, P.; Dickler, M. N.; Gianni, L.; Jansen, V.; Lu, Y.; Young, S.; Rugo, H. S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of abemaciclib on the time to subsequent chemotherapy and the time to second disease progression across the MONARCH 2 and 3 studies
    Meeting Abstract

    Tolaney, S. M.; Di Leo, A.; Llombart Cussac, A.; Dickler, M. N.; Campone, M.; Iwata, H.; Toi, M.; Kaufman, P. A.; Andre, V. A. M.; Barriga, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358
    Meeting Abstract

    Topalian, S. L.; Bhatia, S.; Kudchadkar, R. R.; Amin, A.; Sharfman, W. H.; Lebbe, C.; Delord, J. P.; Shinohara, M. M.; Baxi, S. S.; Chung, C. H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of genomic biomarkers of response to immunotherapy in sarcoma
    Meeting Abstract

    Trabucco, S. E.; Ali, S. M.; Sokol, E.; Betzig Schrock, A.; Albacker, L. A.; Chung, J.; Feldman Xavier, M.; Disel, U.; Miller, V. A.; Ross, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pegilodecakin with nivolumab (nivo) or pembrolizumab (pembro) in patients (pts) with metastatic renal cell carcinoma (RCC)
    Meeting Abstract

    Tannir, N. M.; Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Wong, D. J. L.; Korn, M.; Aljumaily, R.; Autio, K. A.; Pant, S.; Bauer, T. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials
    Meeting Abstract

    Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Katabi, N.; Ni, A.; Haque, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Racial, age, and sex disparities in chronic lymphocytic leukemia (CLL) patients treated with novel therapies
    Meeting Abstract

    Thompson, M.; Nabhan, C.; Cheson, B. D.; Allan, J. N.; Barr, P. M.; Skarbnik, A. P.; Jacobs, R.; Ujjani, C. S.; Furman, R. R.; Schuster, S. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save